Experimental Hidradenitis Suppurativa Therapy Falters in Clinical Trial
In a recent report from Dermatology Times, Acelyrin has disclosed the disappointing outcome of its experimental therapy, izokibep, which failed to meet the primary endpoint in a phase 2b/3 clinical…